Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous esketamine infusion for prevention of postpartum depression and pain after cesarean section
ChiCTR2100047883Phase 4Not yet recruiting
- Sponsor
- Panzhihua Central Hospital
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postpartum depression (PPD) and postoperative pain (2 arms), sponsored by Panzhihua Central Hospital. Primary endpoint: Postoperative depression evaluation index. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2100047883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047883.